These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9271851

  • 1. Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.
    Tschierske M, Ehlert K, Strandén AM, Berger-Bächi B.
    FEMS Microbiol Lett; 1997 Aug 15; 153(2):261-4. PubMed ID: 9271851
    [Abstract] [Full Text] [Related]

  • 2. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM, Ehlert K, Labischinski H, Berger-Bächi B.
    J Bacteriol; 1997 Jan 15; 179(1):9-16. PubMed ID: 8981974
    [Abstract] [Full Text] [Related]

  • 3. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation.
    Ehlert K, Schröder W, Labischinski H.
    J Bacteriol; 1997 Dec 15; 179(23):7573-6. PubMed ID: 9393725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.
    Henze U, Sidow T, Wecke J, Labischinski H, Berger-Bächi B.
    J Bacteriol; 1993 Mar 15; 175(6):1612-20. PubMed ID: 8383661
    [Abstract] [Full Text] [Related]

  • 7. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target?
    Kopp U, Roos M, Wecke J, Labischinski H.
    Microb Drug Resist; 1996 Mar 15; 2(1):29-41. PubMed ID: 9158720
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Degradation of penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus.
    Sumita Y, Fukasawa M, Mitsuhashi S, Inoue M.
    Chemotherapy; 1995 Mar 15; 41(3):172-7. PubMed ID: 7656662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus.
    Moreira B, Boyle-Vavra S, deJonge BL, Daum RS.
    Antimicrob Agents Chemother; 1997 Aug 15; 41(8):1788-93. PubMed ID: 9257762
    [Abstract] [Full Text] [Related]

  • 12. Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.
    Ehlert K, Tschierske M, Mori C, Schröder W, Berger-Bächi B.
    J Bacteriol; 2000 May 15; 182(9):2635-8. PubMed ID: 10762270
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
    Schneider T, Senn MM, Berger-Bächi B, Tossi A, Sahl HG, Wiedemann I.
    Mol Microbiol; 2004 Jul 15; 53(2):675-85. PubMed ID: 15228543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus.
    Nishi H, Komatsuzawa H, Yamada S, Fujiwara T, Ohara M, Ohta K, Sugiyama M, Ishikawa T, Sugai M.
    Microbiol Immunol; 2003 Jul 15; 47(12):927-35. PubMed ID: 14695442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.